Because some of our pharmacological inhibition assays were done in the absence of OP9 cells, all pharmacologically inhibitable Gal3 would have to be that which is endogenous to BCP-ALL cells. This evidence concerns the gene LGALS3 and acute lymphoblastic leukemia.